Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
With ZCC don't we just go to sleep for 3 or 4 years unless Don erodes our equity further?
At least at RVX we have ORI watching guard. :)
GLTA
Toinv